Atlas Venture Advisors’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-112,184	Closed	-$735K	–	5
2024 Q3	$735K	Sell	112,184 -60,000	-35%	-$482K	0.15%	5
2024 Q2	$1.25M	Sell	172,184 -60,000	-26%	-$460K	0.27%	5
2024 Q1	$1.76M	Sell	232,184 -60,000	-21%	-$468K	0.35%	5
2023 Q4	$1.33M	Hold	292,184	–	–	0.23%	5
2023 Q3	$1.15M	Hold	292,184	–	–	0.25%	5
2023 Q2	$915K	Hold	292,184	–	–	0.15%	5
2023 Q1	$1.32M	Hold	292,184	–	–	0.29%	6
2022 Q4	$1.21M	Hold	292,184	–	–	0.42%	7
2022 Q3	$935K	Hold	292,184	–	–	0.34%	7
2022 Q2	$573K	Hold	292,184	–	–	0.18%	7
2022 Q1	$1.18M	Hold	292,184	–	–	0.25%	7
2021 Q4	$3.15M	Hold	292,184	–	–	0.44%	6
2021 Q3	$3.37M	Hold	292,184	–	–	0.4%	8
2021 Q2	$2.87M	Hold	292,184	–	–	0.3%	9
2021 Q1	$4.27M	Hold	292,184	–	–	0.79%	7
2020 Q4	$6.26M	Hold	292,184	–	–	1.4%	6
2020 Q3	$4.43M	Hold	292,184	–	–	0.75%	7
2020 Q2	$3.75M	Hold	292,184	–	–	0.96%	7
2020 Q1	$2.7M	Hold	292,184	–	–	3.66%	6
2019 Q4	$3.89M	Hold	292,184	–	–	5.88%	6
2019 Q3	$2.59M	Hold	292,184	–	–	0.8%	6
2019 Q2	$4.17M	Hold	292,184	–	–	1.73%	5
2019 Q1	$9.61M	Hold	292,184	–	–	4.85%	3
2018 Q4	$17.4M	Buy	+292,184	New	+$28.8M	9.16%	3